Phase II Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or Above
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Respiratory Syncytial Virus
Related studies linked through entity extraction aliases.
Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or Above
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea
- Status
- RECRUITING
- Phase
- N/A
STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in Korea
- Status
- COMPLETED
- Phase
- PHASE3
Assessing Antiviral Treatments in Early Symptomatic RSV
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants
- Status
- COMPLETED
- Phase
- PHASE3
BEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study)
- Status
- COMPLETED
- Phase
- N/A
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study
- Status
- COMPLETED
- Phase
- N/A
Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Modified mRNA Vaccines in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3